Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany.
Elena SchäferMonika MaleckiCarlos J Tellez-CastilloNiels PfennigwerthLennart MarlinghausPaul G HigginsFrauke MattnerAndreas F WendelPublished in: Antimicrobial resistance and infection control (2019)
These data give insight into the epidemiology of CPPA in three centres in Germany over a period of 3 years. Carbapenemases are a relevant resistance mechanism in 4MRGN-P. aeruginosa, illustrated by genetically related VIM-2-producing strains that seem to be endemic in this region. Our data suggest that infection control measures should especially focus on controlling transmission on the ICU and support the need for a local molecular surveillance system.